Menlo Park, CA, United States of America

Junko F Stevens

USPTO Granted Patents = 11 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Junko F Stevens: Innovator in Nucleic Acid Amplification

Introduction

Junko F Stevens is a prominent inventor based in Menlo Park, CA (US), known for his significant contributions to the field of molecular biology. With a total of 11 patents, Stevens has made remarkable advancements in the methods and compositions used for nucleic acid amplification.

Latest Patents

Stevens' latest patents include innovative compositions, methods, and kits for real-time polymerase chain reaction (PCR). These inventions focus on amplifying target nucleic acids while minimizing non-specific amplification and undesired products. One of his notable patents describes a dual hot start reaction mixture that utilizes at least two different hot start mechanisms. Another patent outlines methods for amplifying nucleic acids while reducing non-specific fluorescence and secondary amplification products. The enzyme inhibitors detailed in these patents comprise a nucleotide sequence and at least one quencher, providing a novel approach to enhancing the efficiency of nucleic acid amplification.

Career Highlights

Throughout his career, Junko F Stevens has worked with leading companies in the biotechnology sector, including Life Technologies Corporation and Applied Biosystems, LLC. His expertise in nucleic acid amplification has positioned him as a key figure in the development of advanced molecular biology techniques.

Collaborations

Stevens has collaborated with notable colleagues in his field, including Shoulian Dong and Carole Bornarth, who have contributed to his research and development efforts.

Conclusion

Junko F Stevens continues to be a driving force in the innovation of nucleic acid amplification technologies. His patents and collaborations reflect his commitment to advancing molecular biology and improving research methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…